nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.0271	0.037	CcSEcCtD
Rizatriptan—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.0163	0.0223	CcSEcCtD
Rizatriptan—Ataxia—Spironolactone—dilated cardiomyopathy	0.0118	0.0161	CcSEcCtD
Rizatriptan—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0113	0.0155	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0113	0.0155	CcSEcCtD
Rizatriptan—Gastritis—Spironolactone—dilated cardiomyopathy	0.0111	0.0152	CcSEcCtD
Rizatriptan—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.0109	0.0148	CcSEcCtD
Rizatriptan—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00989	0.0135	CcSEcCtD
Rizatriptan—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00922	0.0126	CcSEcCtD
Rizatriptan—Memory impairment—Lisinopril—dilated cardiomyopathy	0.009	0.0123	CcSEcCtD
Rizatriptan—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00872	0.0119	CcSEcCtD
Rizatriptan—Urine output increased—Furosemide—dilated cardiomyopathy	0.00851	0.0116	CcSEcCtD
Rizatriptan—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00778	0.0106	CcSEcCtD
Rizatriptan—Polyuria—Furosemide—dilated cardiomyopathy	0.00778	0.0106	CcSEcCtD
Rizatriptan—Swelling—Furosemide—dilated cardiomyopathy	0.00774	0.0106	CcSEcCtD
Rizatriptan—Deafness—Furosemide—dilated cardiomyopathy	0.00764	0.0104	CcSEcCtD
Rizatriptan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00727	0.00994	CcSEcCtD
Rizatriptan—Thirst—Furosemide—dilated cardiomyopathy	0.00718	0.00981	CcSEcCtD
Rizatriptan—Neck pain—Lisinopril—dilated cardiomyopathy	0.00715	0.00977	CcSEcCtD
Rizatriptan—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00715	0.00977	CcSEcCtD
Rizatriptan—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00706	0.00965	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00706	0.00965	CcSEcCtD
Rizatriptan—Wheezing—Lisinopril—dilated cardiomyopathy	0.00686	0.00937	CcSEcCtD
Rizatriptan—Photophobia—Lisinopril—dilated cardiomyopathy	0.00663	0.00906	CcSEcCtD
Rizatriptan—Irritability—Furosemide—dilated cardiomyopathy	0.00652	0.00891	CcSEcCtD
Rizatriptan—Discomfort—Spironolactone—dilated cardiomyopathy	0.00636	0.00869	CcSEcCtD
Rizatriptan—Dehydration—Furosemide—dilated cardiomyopathy	0.00635	0.00868	CcSEcCtD
Rizatriptan—Confusional state—Spironolactone—dilated cardiomyopathy	0.00622	0.0085	CcSEcCtD
Rizatriptan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00617	0.00843	CcSEcCtD
Rizatriptan—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00615	0.00841	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00615	0.00841	CcSEcCtD
Rizatriptan—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00603	0.00823	CcSEcCtD
Rizatriptan—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00594	0.00812	CcSEcCtD
Rizatriptan—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00584	0.00798	CcSEcCtD
Rizatriptan—Somnolence—Spironolactone—dilated cardiomyopathy	0.00549	0.0075	CcSEcCtD
Rizatriptan—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00545	0.00745	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00539	0.00737	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00533	0.00728	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0053	0.00724	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00523	0.00715	CcSEcCtD
Rizatriptan—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00513	0.00701	CcSEcCtD
Rizatriptan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00509	0.00695	CcSEcCtD
Rizatriptan—Sweating—Furosemide—dilated cardiomyopathy	0.00505	0.0069	CcSEcCtD
Rizatriptan—Face oedema—Lisinopril—dilated cardiomyopathy	0.00495	0.00676	CcSEcCtD
Rizatriptan—Urticaria—Spironolactone—dilated cardiomyopathy	0.0049	0.0067	CcSEcCtD
Rizatriptan—Irritability—Lisinopril—dilated cardiomyopathy	0.00489	0.00669	CcSEcCtD
Rizatriptan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00488	0.00667	CcSEcCtD
Rizatriptan—Ataxia—Lisinopril—dilated cardiomyopathy	0.00482	0.00659	CcSEcCtD
Rizatriptan—Dehydration—Lisinopril—dilated cardiomyopathy	0.00477	0.00651	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00462	0.00631	CcSEcCtD
Rizatriptan—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00462	0.00631	CcSEcCtD
Rizatriptan—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00458	0.00626	CcSEcCtD
Rizatriptan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00455	0.00621	CcSEcCtD
Rizatriptan—Gastritis—Lisinopril—dilated cardiomyopathy	0.00454	0.0062	CcSEcCtD
Rizatriptan—Tinnitus—Furosemide—dilated cardiomyopathy	0.00441	0.00602	CcSEcCtD
Rizatriptan—Pruritus—Spironolactone—dilated cardiomyopathy	0.00437	0.00597	CcSEcCtD
Rizatriptan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00432	0.0059	CcSEcCtD
Rizatriptan—Angiopathy—Furosemide—dilated cardiomyopathy	0.00429	0.00586	CcSEcCtD
Rizatriptan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00422	0.00577	CcSEcCtD
Rizatriptan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00422	0.00577	CcSEcCtD
Rizatriptan—Dysuria—Lisinopril—dilated cardiomyopathy	0.00414	0.00566	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00412	0.00563	CcSEcCtD
Rizatriptan—Erythema—Furosemide—dilated cardiomyopathy	0.00411	0.00562	CcSEcCtD
Rizatriptan—Dizziness—Spironolactone—dilated cardiomyopathy	0.00408	0.00558	CcSEcCtD
Rizatriptan—Flatulence—Furosemide—dilated cardiomyopathy	0.00405	0.00554	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00404	0.00553	CcSEcCtD
Rizatriptan—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00403	0.00551	CcSEcCtD
Rizatriptan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00396	0.00541	CcSEcCtD
Rizatriptan—Vomiting—Spironolactone—dilated cardiomyopathy	0.00392	0.00536	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00389	0.00532	CcSEcCtD
Rizatriptan—Rash—Spironolactone—dilated cardiomyopathy	0.00389	0.00532	CcSEcCtD
Rizatriptan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00389	0.00531	CcSEcCtD
Rizatriptan—Vision blurred—Furosemide—dilated cardiomyopathy	0.00388	0.0053	CcSEcCtD
Rizatriptan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00387	0.00529	CcSEcCtD
Rizatriptan—Headache—Spironolactone—dilated cardiomyopathy	0.00387	0.00528	CcSEcCtD
Rizatriptan—Sweating—Lisinopril—dilated cardiomyopathy	0.00379	0.00518	CcSEcCtD
Rizatriptan—Agitation—Furosemide—dilated cardiomyopathy	0.00378	0.00517	CcSEcCtD
Rizatriptan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00373	0.00509	CcSEcCtD
Rizatriptan—Vertigo—Furosemide—dilated cardiomyopathy	0.0037	0.00505	CcSEcCtD
Rizatriptan—Nausea—Spironolactone—dilated cardiomyopathy	0.00367	0.00501	CcSEcCtD
Rizatriptan—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00361	0.00493	CcSEcCtD
Rizatriptan—Hallucination—Lisinopril—dilated cardiomyopathy	0.00353	0.00482	CcSEcCtD
Rizatriptan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00352	0.00481	CcSEcCtD
Rizatriptan—Dry mouth—Furosemide—dilated cardiomyopathy	0.00343	0.00468	CcSEcCtD
Rizatriptan—Confusional state—Furosemide—dilated cardiomyopathy	0.00339	0.00463	CcSEcCtD
Rizatriptan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00336	0.00459	CcSEcCtD
Rizatriptan—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00331	0.00452	CcSEcCtD
Rizatriptan—Shock—Furosemide—dilated cardiomyopathy	0.0033	0.00451	CcSEcCtD
Rizatriptan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00329	0.0045	CcSEcCtD
Rizatriptan—Flushing—Lisinopril—dilated cardiomyopathy	0.00329	0.0045	CcSEcCtD
Rizatriptan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00325	0.00444	CcSEcCtD
Rizatriptan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00322	0.0044	CcSEcCtD
Rizatriptan—Anorexia—Furosemide—dilated cardiomyopathy	0.0032	0.00437	CcSEcCtD
Rizatriptan—Chills—Lisinopril—dilated cardiomyopathy	0.00318	0.00435	CcSEcCtD
Rizatriptan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00317	0.00433	CcSEcCtD
Rizatriptan—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00311	0.00425	CcSEcCtD
Rizatriptan—Erythema—Lisinopril—dilated cardiomyopathy	0.00309	0.00422	CcSEcCtD
Rizatriptan—Flatulence—Lisinopril—dilated cardiomyopathy	0.00304	0.00416	CcSEcCtD
Rizatriptan—Tension—Lisinopril—dilated cardiomyopathy	0.00303	0.00414	CcSEcCtD
Rizatriptan—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00302	0.00413	CcSEcCtD
Rizatriptan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00302	0.00412	CcSEcCtD
Rizatriptan—Nervousness—Lisinopril—dilated cardiomyopathy	0.003	0.0041	CcSEcCtD
Rizatriptan—Somnolence—Furosemide—dilated cardiomyopathy	0.00299	0.00408	CcSEcCtD
Rizatriptan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00297	0.00406	CcSEcCtD
Rizatriptan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00292	0.00399	CcSEcCtD
Rizatriptan—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00291	0.00398	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0029	0.00396	CcSEcCtD
Rizatriptan—Fatigue—Furosemide—dilated cardiomyopathy	0.00289	0.00396	CcSEcCtD
Rizatriptan—Tremor—Lisinopril—dilated cardiomyopathy	0.00289	0.00395	CcSEcCtD
Rizatriptan—Pain—Furosemide—dilated cardiomyopathy	0.00287	0.00392	CcSEcCtD
Rizatriptan—Constipation—Furosemide—dilated cardiomyopathy	0.00287	0.00392	CcSEcCtD
Rizatriptan—Angioedema—Lisinopril—dilated cardiomyopathy	0.00282	0.00385	CcSEcCtD
Rizatriptan—Vertigo—Lisinopril—dilated cardiomyopathy	0.00277	0.00379	CcSEcCtD
Rizatriptan—Syncope—Lisinopril—dilated cardiomyopathy	0.00277	0.00378	CcSEcCtD
Rizatriptan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00277	0.00378	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00275	0.00375	CcSEcCtD
Rizatriptan—Palpitations—Lisinopril—dilated cardiomyopathy	0.00273	0.00373	CcSEcCtD
Rizatriptan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00271	0.00371	CcSEcCtD
Rizatriptan—Cough—Lisinopril—dilated cardiomyopathy	0.00269	0.00368	CcSEcCtD
Rizatriptan—Urticaria—Furosemide—dilated cardiomyopathy	0.00267	0.00365	CcSEcCtD
Rizatriptan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00265	0.00363	CcSEcCtD
Rizatriptan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00265	0.00363	CcSEcCtD
Rizatriptan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00263	0.00359	CcSEcCtD
Rizatriptan—Myalgia—Lisinopril—dilated cardiomyopathy	0.00263	0.00359	CcSEcCtD
Rizatriptan—Chest pain—Lisinopril—dilated cardiomyopathy	0.00263	0.00359	CcSEcCtD
Rizatriptan—Anxiety—Lisinopril—dilated cardiomyopathy	0.00262	0.00358	CcSEcCtD
Rizatriptan—Discomfort—Lisinopril—dilated cardiomyopathy	0.0026	0.00355	CcSEcCtD
Rizatriptan—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00257	0.00351	CcSEcCtD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00255	0.00952	CbGpPWpGaD
Rizatriptan—Confusional state—Lisinopril—dilated cardiomyopathy	0.00254	0.00347	CcSEcCtD
Rizatriptan—Oedema—Lisinopril—dilated cardiomyopathy	0.00252	0.00344	CcSEcCtD
Rizatriptan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00252	0.00344	CcSEcCtD
Rizatriptan—Shock—Lisinopril—dilated cardiomyopathy	0.00248	0.00339	CcSEcCtD
Rizatriptan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00247	0.00338	CcSEcCtD
Rizatriptan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00246	0.00336	CcSEcCtD
Rizatriptan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00244	0.00333	CcSEcCtD
Rizatriptan—Asthenia—Furosemide—dilated cardiomyopathy	0.00241	0.00329	CcSEcCtD
Rizatriptan—Anorexia—Lisinopril—dilated cardiomyopathy	0.0024	0.00328	CcSEcCtD
Rizatriptan—Pruritus—Furosemide—dilated cardiomyopathy	0.00238	0.00325	CcSEcCtD
Rizatriptan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0023	0.00314	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.0023	0.00314	CcSEcCtD
Rizatriptan—Insomnia—Lisinopril—dilated cardiomyopathy	0.00228	0.00311	CcSEcCtD
Rizatriptan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00226	0.00309	CcSEcCtD
Rizatriptan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00225	0.00307	CcSEcCtD
Rizatriptan—Somnolence—Lisinopril—dilated cardiomyopathy	0.00224	0.00306	CcSEcCtD
Rizatriptan—Dizziness—Furosemide—dilated cardiomyopathy	0.00222	0.00303	CcSEcCtD
Rizatriptan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00222	0.00303	CcSEcCtD
Rizatriptan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00219	0.00299	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00218	0.00297	CcSEcCtD
Rizatriptan—Fatigue—Lisinopril—dilated cardiomyopathy	0.00217	0.00297	CcSEcCtD
Rizatriptan—Constipation—Lisinopril—dilated cardiomyopathy	0.00215	0.00294	CcSEcCtD
Rizatriptan—Pain—Lisinopril—dilated cardiomyopathy	0.00215	0.00294	CcSEcCtD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00214	0.00796	CbGpPWpGaD
Rizatriptan—Vomiting—Furosemide—dilated cardiomyopathy	0.00213	0.00292	CcSEcCtD
Rizatriptan—MAOA—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00213	0.00796	CbGpPWpGaD
Rizatriptan—Rash—Furosemide—dilated cardiomyopathy	0.00212	0.00289	CcSEcCtD
Rizatriptan—Dermatitis—Furosemide—dilated cardiomyopathy	0.00212	0.00289	CcSEcCtD
Rizatriptan—Headache—Furosemide—dilated cardiomyopathy	0.0021	0.00287	CcSEcCtD
Rizatriptan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00208	0.00284	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00206	0.00282	CcSEcCtD
Rizatriptan—HTR1F—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00203	0.00755	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00203	0.00755	CbGpPWpGaD
Rizatriptan—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00201	0.0075	CbGpPWpGaD
Rizatriptan—Urticaria—Lisinopril—dilated cardiomyopathy	0.002	0.00274	CcSEcCtD
Rizatriptan—Nausea—Furosemide—dilated cardiomyopathy	0.00199	0.00273	CcSEcCtD
Rizatriptan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00199	0.00272	CcSEcCtD
Rizatriptan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00199	0.00272	CcSEcCtD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00188	0.00702	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00188	0.00701	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00186	0.00254	CcSEcCtD
Rizatriptan—Asthenia—Lisinopril—dilated cardiomyopathy	0.00181	0.00247	CcSEcCtD
Rizatriptan—Pruritus—Lisinopril—dilated cardiomyopathy	0.00178	0.00244	CcSEcCtD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00175	0.00651	CbGpPWpGaD
Rizatriptan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00172	0.00236	CcSEcCtD
Rizatriptan—MAOA—Neuronal System—ABCC9—dilated cardiomyopathy	0.00171	0.00636	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00169	0.00631	CbGpPWpGaD
Rizatriptan—Dizziness—Lisinopril—dilated cardiomyopathy	0.00167	0.00228	CcSEcCtD
Rizatriptan—MAOA—Neuronal System—ACTN2—dilated cardiomyopathy	0.00164	0.0061	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00161	0.006	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00161	0.006	CbGpPWpGaD
Rizatriptan—Vomiting—Lisinopril—dilated cardiomyopathy	0.0016	0.00219	CcSEcCtD
Rizatriptan—Rash—Lisinopril—dilated cardiomyopathy	0.00159	0.00217	CcSEcCtD
Rizatriptan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00159	0.00217	CcSEcCtD
Rizatriptan—Headache—Lisinopril—dilated cardiomyopathy	0.00158	0.00216	CcSEcCtD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0015	0.00558	CbGpPWpGaD
Rizatriptan—Nausea—Lisinopril—dilated cardiomyopathy	0.0015	0.00205	CcSEcCtD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00145	0.00541	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00145	0.00539	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00137	0.00511	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0013	0.00483	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0013	0.00483	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00127	0.00473	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00127	0.00473	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00124	0.00462	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00123	0.00457	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00123	0.00457	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0012	0.00449	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0012	0.00448	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00118	0.0044	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00118	0.00439	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00118	0.00438	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00117	0.00437	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00114	0.00425	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00112	0.00417	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0011	0.00412	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0011	0.00409	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00109	0.00408	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00108	0.00403	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00106	0.00395	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00103	0.00384	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00103	0.00384	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00102	0.00379	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00101	0.00376	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00101	0.00376	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000997	0.00372	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000966	0.0036	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000966	0.0036	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000958	0.00357	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000943	0.00352	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000938	0.0035	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000929	0.00346	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000927	0.00346	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000925	0.00345	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000908	0.00338	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000905	0.00337	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000898	0.00335	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000897	0.00334	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000895	0.00334	CbGpPWpGaD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000892	0.00333	CbGpPWpGaD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000877	0.00327	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000872	0.00325	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000864	0.00322	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000859	0.0032	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000834	0.00311	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000807	0.00301	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000792	0.00295	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000784	0.00292	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000784	0.00292	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000776	0.00289	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000768	0.00286	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000768	0.00286	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000768	0.00286	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000768	0.00286	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000751	0.0028	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000736	0.00274	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000729	0.00272	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000714	0.00266	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000714	0.00266	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000706	0.00263	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000701	0.00261	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000693	0.00258	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000693	0.00258	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000692	0.00258	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000692	0.00258	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00069	0.00257	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000686	0.00256	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ANKRD1—dilated cardiomyopathy	0.000667	0.00249	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000664	0.00247	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000654	0.00244	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000644	0.0024	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00063	0.00235	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00063	0.00235	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TAZ—dilated cardiomyopathy	0.000627	0.00234	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000624	0.00233	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000603	0.00225	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000591	0.0022	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000591	0.0022	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000585	0.00218	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000585	0.00218	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000585	0.00218	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00058	0.00216	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000572	0.00213	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SDHA—dilated cardiomyopathy	0.000567	0.00211	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000567	0.00211	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000561	0.00209	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00056	0.00209	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000557	0.00208	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000552	0.00206	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000546	0.00203	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000544	0.00203	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000533	0.00199	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000527	0.00196	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000523	0.00195	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000519	0.00193	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000506	0.00188	CbGpPWpGaD
Rizatriptan—MAOA—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000486	0.00181	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000484	0.0018	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000459	0.00171	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00045	0.00168	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000443	0.00165	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000443	0.00165	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000434	0.00162	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000434	0.00162	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000427	0.00159	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000424	0.00158	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000419	0.00156	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000416	0.00155	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000416	0.00155	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000412	0.00154	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000404	0.0015	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000403	0.0015	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000403	0.0015	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000399	0.00149	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000398	0.00148	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000398	0.00148	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000394	0.00147	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000394	0.00147	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000393	0.00146	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000391	0.00146	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000387	0.00144	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000379	0.00141	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000379	0.00141	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000375	0.0014	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000374	0.00139	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—RAF1—dilated cardiomyopathy	0.000372	0.00139	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000372	0.00139	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000372	0.00139	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000366	0.00137	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000362	0.00135	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000357	0.00133	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000355	0.00132	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000346	0.00129	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000341	0.00127	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000341	0.00127	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000335	0.00125	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000334	0.00124	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000331	0.00123	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000331	0.00123	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000329	0.00123	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000323	0.00121	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000317	0.00118	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000317	0.00118	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00031	0.00115	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000307	0.00115	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000303	0.00113	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0003	0.00112	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0003	0.00112	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000298	0.00111	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000294	0.00109	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000288	0.00107	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000286	0.00107	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000279	0.00104	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000271	0.00101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00027	0.00101	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000268	0.000998	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000262	0.000977	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000254	0.000948	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000251	0.000936	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000246	0.000917	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000246	0.000916	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000241	0.000899	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00024	0.000894	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000238	0.000886	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000238	0.000886	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000236	0.000881	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000235	0.000875	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000233	0.000869	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000233	0.000868	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000233	0.000868	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000231	0.000862	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000231	0.000861	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000228	0.00085	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000223	0.000832	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000221	0.000824	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000219	0.000816	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000218	0.000812	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000216	0.000807	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000214	0.000798	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000213	0.000795	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000211	0.000785	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00021	0.000781	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000209	0.000779	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AGT—dilated cardiomyopathy	0.000201	0.00075	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.0002	0.000745	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000187	0.000698	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000183	0.000682	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000179	0.000667	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000179	0.000667	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000177	0.000661	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000177	0.000661	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000173	0.000647	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00017	0.000634	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00017	0.000633	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000165	0.000615	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000162	0.000606	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000162	0.000604	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00016	0.000595	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GPX1—dilated cardiomyopathy	0.000154	0.000574	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000151	0.000563	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CD36—dilated cardiomyopathy	0.00015	0.000559	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000149	0.000556	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000148	0.000552	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000146	0.000544	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00014	0.000521	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000136	0.000508	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AGT—dilated cardiomyopathy	0.000135	0.000503	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000135	0.000502	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000132	0.000492	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000482	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000129	0.00048	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000128	0.000475	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000126	0.00047	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000124	0.000463	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000113	0.00042	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000112	0.000417	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000111	0.000414	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000104	0.000386	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000102	0.000378	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.0001	0.000374	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.6e-05	0.000358	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—dilated cardiomyopathy	9.58e-05	0.000357	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	8.93e-05	0.000333	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.74e-05	0.000326	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.73e-05	0.000288	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.66e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	6.12e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6e-05	0.000224	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.68e-05	0.000212	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	5.53e-05	0.000206	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	4.98e-05	0.000186	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.57e-05	0.00017	CbGpPWpGaD
